Liver Disease
From the AGA Journals
Rebranding NAFLD: Correcting ‘Flawed’ Conventions
Steatotic liver disease now comprises five disease subtypes that can be determined via an algorithm.
Latest News
Is There a Safe Alcohol Limit in Early Liver Disease?
The mortality rate per 100,000 persons was 4342 in the group with intermediate and high risk for advanced fibrosis versus 1099 in the low-risk...
Perspectives
Exploring the impact of substance use on liver transplantation
The ethics of liver transplantation in the setting of severe alcohol-associated hepatitis are complex and still controversial.
Member Spotlight
Hepatologist finds purpose as health equity advocate for LGBTQI+
Fighting to promote health care equity in the LGBTQI+ population has been a cornerstone of her career.
From the AGA Journals
NAFLD familial risk score outperforms FIB-4 index for identifying advanced fibrosis
Analysis identifies four risk factors for advanced fibrosis.
Pearls from the Pros
Statins and the liver: Not harmful and perhaps beneficial
Statins should not be withheld in patients with liver disease when indicated — with a few caveats.
From the AGA Journals
AGA CPU updates usage of vasoactive drugs, IV albumin, for cirrhosis
CPU includes 12 best-practice-advice statements concerning 3 common clinical scenarios: variceal hemorrhage, ascites and spontaneous bacterial...
Conference Coverage
Fewer than 1 out of 4 patients with HCV-related liver cancer receive antivirals
This study and others suggest that these practice-altering agents are underutilized. Greater awareness of direct-acting antiviral agents is needed...
Conference Coverage
Taste and smell changes linked with worse QOL and cognition in cirrhosis, renal failure
Clinicians should screen for changes in taste and smell among patients at risk of cognitive changes.
Conference Coverage
COVID livers are safe for transplant
Using livers from deceased patients with COVID-19 could be an opportunity expand organ availability.